NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

0.0%

Nov 3 11:17 AM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Ron who wrote ()	3/16/1998 1:47:00 PM
From: Ron	of 132

Here is one of the articles for those interested in both this stock and in Alzheimers treatment: NEW YORK--(BUSINESS WIRE)--March 16, 1998-- Scientists from Nymox Pharmaceutical Corporation (NASDAQ National Market: NYMXF; Montreal Exchange: NMX) announced today at the Manhattan Alzheimer's Disease conference in New York City that they believe they have found a major cause of Alzheimer's disease. The peer-reviewed research results appear in the March issue of The Journal of Alzheimer's Disease. The Nymox Pharmaceutical Corporation research team has discovered a new human brain entity called the ''spheron'' which they say satisfies 20 criteria of validity as a causal entity for Alzheimer's disease. The Company, which has patents on the spherons, their use in diagnostics and therapeutics, as well as the spheron based new chemical entities, has several new drug candidates in development based on the spherons, treatments which may eventually be capable of slowing or stopping the disease. Nymox cautions that the spheron based Nymox Alzheimer candidate drugs, while showing exciting dramatic positive effects in the test tube and in animals, and while showing no toxicity thus far, have not yet been tested in humans.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext